Osaic Holdings
DERM icon

Osaic Holdings’s Journey Medical DERM Stock Holding History

Osaic Holdings’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.6K Sell
8,647
-400
-4% -$3.1K ﹤0.01% 5367
2025
Q4 		$69.7K Sell
9,047
-3,135
-26% -$24.6K ﹤0.01% 5002
2025
Q3 		$87.7K Sell
12,182
-1,419
-10% -$10.3K ﹤0.01% 4899
2025
Q2 		$97.6K Sell
13,601
-1,011
-7% -$6.99K ﹤0.01% 4522
2025
Q1 		$86.2K Buy
14,612
+2,596
+22% +$12.8K ﹤0.01% 4284
2024
Q4 		$47K Buy
12,016
+9,037
+303% +$49.4K ﹤0.01% 4756
2024
Q3 		$16.8K Buy
2,979
+2,579
+645% +$13.3K ﹤0.01% 5483
2024
Q2 		$2.26K Buy
+400
New +$1.65K ﹤0.01% 6550
2024
Q1 		– Sell
-5,455
Closed -$31.4K – 7234
2023
Q4 		$31.4K Buy
+5,455
New +$24.3K ﹤0.01% 5211

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Osaic Holdings's DERM Position: Q1 2026 in Review

Osaic Holdings reduced its Journey Medical (DERM) stake by 4.4% in Q1 2026, selling an estimated $3.1K and leaving 8,647 shares worth $40.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5367.

Osaic Holdings first reported a position in DERM in Q4 2023 and has held it in 9 quarters since. The position peaked at $97.6K in Q2 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Osaic Holdings held 8,647 shares of Journey Medical worth $40.6K as of Q1 2026.
  • Osaic Holdings sold 400 Journey Medical shares in Q1 2026, an estimated $3.1K.
  • Journey Medical made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5367 holding.
  • Osaic Holdings first reported a position in Journey Medical in Q4 2023 and has held it in 9 quarters since.
  • Osaic Holdings's Journey Medical position peaked at $97.6K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.